Skip to main content
. 2023 Oct 27;7(23):7209–7215. doi: 10.1182/bloodadvances.2023011366

Table 4.

Minimum FVIII level to prevent total and spontaneous joint bleeds

Outcomes for all joint bleeds AUC YI FVIII level
At least 1 joint bleeding episode in life 0.73 0.39 19.2
At least 1 joint bleeding episode in the 1st quartile of age (<28) 0.68 0.34 19.2
At least 1 joint bleeding episode in the 2nd quartile of age (28 ≤ x < 45) 0.73 0.41 14.0
At least 1 joint bleeding episode in the 3rd quartile of age (45 ≤ x < 59)§ 0.71 0.41 12.8
At least 1 joint bleeding episode in the 4th quartile of age (≥59) 0.80 0.47 14.3
Outcomes for spontaneous joint bleeds
At least 1 spontaneous joint bleeding episode in life 0.80 0.58 17.7
At least 1 spontaneous joint bleed in the 1st quartile of age (<28)# 0.85 0.67 17.7
At least 1 spontaneous joint bleed in the 2nd quartile of age (28 ≤ x < 45)∗∗ 0.88 0.71 16.7
At least 1 spontaneous joint bleed in the 3rd quartile of age (45 ≤ x < 59)†† NA NA NA
At least 1 spontaneous joint bleed in the 4th quartile of age (≥59)‡‡ 0.92 0.87 12.8

FVIII level indicates the minimum (trough) FVIII level to achieve zero joint bleeds (total or spontaneous).

NA, non applicable; YI, Youden Index (sensitivity + specificity – 1).

Available in 270 patients.

Available in 266 patients.

Available/applicable in 203 patients.

§

Available/applicable in 130 patients.

Available/applicable in 66 patients

Available in 240 patients.

#

Available in 238 patients.

∗∗

Available/applicable in 180 patients.

††

Available/applicable in 115 patients.

‡‡

Available/applicable in 56 patients.